Anti-ICOS Ligand/ICOSL 抗体 [EPR20786]
Anti-ICOS Ligand/ICOSL antibody [EPR20786]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal ICOS Ligand/ICOSL antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication.
別名を表示する
CD275, B7H2, B7RP1, ICOSL, KIAA0653, ICOSLG, ICOS ligand, B7 homolog 2, B7-like protein Gl50, B7-related protein 1, B7-H2, B7RP-1
- IP
Supplier Data
Immunoprecipitation - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
ICOS Ligand/ICOSL was immunoprecipitated from 0.35 mg JAR (human placenta choriocarcinoma cell line) whole cell lysate with ab230946 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab230946 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : JAR (human placenta choriocarcinoma cell line) whole cell lysate 10 μg (Input).
Lane 2 : ab230946 IP in JAR whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab230946 in JAR whole cell lysate (-).
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946)
Predicted band size: 33 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure times :
Lane 1 : 15 seconds.
Lane 2 : 84 seconds.
ICOS ligand/ICOSL is highly glycosylated (PMID11983910).
All lanes:
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution
Lane 1:
HuT-78 (human Sezary syndrome cutaneous T lymphocyte) whole cell lysate at 20 µg
Lane 2:
JAR (human placenta choriocarcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 33 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 58 seconds.
The level of ICOS Ligand/ICOSL expression can be elevated by TNF-alpha treatment (PMID 11983910,PMID16049332).
All lanes:
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution
Lane 1:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 10 µg
Lane 2:
HUVEC whole cell lysate treated with tumor necrosis factor (TNF-alpha, <a href='/products/proteins-peptides/recombinant-human-tnf-alpha-protein-ab9642'>ab9642</a>) 200 unit/ml for 24 hours at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 33 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (AB230946)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 15 seconds.
All lanes:
Western blot - Anti-ICOS Ligand/ICOSL antibody [EPR20786] (ab230946) at 1/1000 dilution
All lanes:
His-tagged recombinant human ICOS ligand/ICOSL protein (aa19-258) at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 33 kDa
Observed band size: 55 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-ICOS Ligand/ICOSL antibody [EPR20786] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ICOSL contributes to the modulation of immune responses. By forming a complex with the active ICOS protein ICOSL is involved in the co-stimulation of T cells. This process is important for the development of T-cell-dependent immune responses and helps in promoting the survival and differentiation of T cells. Together the ICOS ligand and ICOS protein create a dynamic interaction that balances immune activation and tolerance which is essential for maintaining immune homeostasis.
Pathways
The ICOS-ICOSL interaction plays an important role in the T-cell receptor (TCR) signaling pathway. This pathway is fundamental for the activation of T cells and subsequent immune response. ICOSL also connects to the PI3K/Akt pathway where it impacts cell survival and proliferation. ICOS and the PI3K/Akt pathway work together to influence various aspects of immune regulation and adaptive immunity.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Microorganisms 11: PubMed36838330
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com